Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 13 Jan 2026 | Florika Fink-Hooijer Director-General | Exchange between HERA and Bavarian Nordic | — |
| 13 Jan 2026 | Florika Fink-Hooijer Director-General | Exchange between HERA and Bavarian Nordic | SRC |
| 12 Nov 2025 | Maciej Popowski Director-General | Cooperation with EU, on biodefence, for instance in the context of implementing the stockpiling strategy. | — |
| 12 Nov 2025 | Maciej Popowski Director-General | Cooperation with EU, on biodefence, for instance in the context of implementing the stockpiling strategy. | SRC |
| 29 Sept 2025 | Sandra Gallina Director-General | EU pharmaceutical and health security policy | — |
| 29 Sept 2025 | Sandra Gallina Director-General | EU pharmaceutical and health security policy | SRC |
Mission & Goals
Bavarian Nordic is a leading global provider of travel vaccines and a preferred partner with governments and international organizations on delivering vaccines for improving public preparedness, such as for mpox and smallpox. WIth more than 30 years of vaccine excellence, BN employs more than 1,600 people specialized in research and development, manufacturing and commercialization of vaccines and is headquartered in Denmark and have facilities in the Germany, Switzerland, USA. BN has established a commercial infrastructure with presence in key markets in Europe and the USA to serve our customers with an expanding portfolio of vaccines.
EU Legislative Interests
HERA, HaDEA, RescEU, EU4Health
Communication Activities
N/A
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Bavarian Nordic is a member of EUCOPE (EuropeanConfederation of Pharmaceutical Entrepreneurs), a trade association of small and mid-sized pharmaceutical and biotech companies in Europe.
Organisation Members
N/A